HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $360K of Halozyme Therapeutics, Inc.
Sold$360,000
$36.00Price
10,000Shares
−7%Stake
What HALO did after the filing
- The stock from Thu, Jun 22 close, $35.43
- +19.7%
- S&P 500, same days
- +2.4%
Measured over 30 trading days, to the Aug 4 close.
Traded Wed, Jun 21. Filed Thu, Jun 22, 2:20 PM ET, during the session. Returns use the Jun 22 close and the Aug 4 close. Not investment advice.